This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Daniel Liebler, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT00897403
First received: May 9, 2009
Last updated: April 5, 2017
Last verified: April 2017
May 9, 2009
April 5, 2017
December 2006
August 2015   (Final data collection date for primary outcome measure)
Collection of blood and tissue [ Time Frame: Pre-op & during surgery ]
Collection of blood and tissue
Complete list of historical versions of study NCT00897403 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
Discovery of Candidate Biomarkers in Colon Cancer and Precancers Repository

RATIONALE: Collecting and storing samples of blood and tissue from patients undergoing colonoscopy to study in the laboratory may help doctors learn more about colon cancer and identify biomarkers related to colon cancer in the future.

PURPOSE: This laboratory study is collecting blood and tissue samples for future colon cancer biomarker studies in patients undergoing colonoscopy.

OBJECTIVES:

  • Collect blood and tissue samples (including polyps, abnormal growths, cancer, and normal tissue) from patients undergoing colonoscopy.

OUTLINE: Patients undergo blood and tissue sample collection during colonoscopy. Samples are stored for future biomarker proteomic profiling.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients scheduled for colonoscopy either as routine screening or for a specific problem.
  • Colorectal Cancer
  • Health Status Unknown
  • Other: biologic sample preservation procedure
  • Procedure: diagnostic colonoscopy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
6446
April 2016
August 2015   (Final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Scheduled for colonoscopy as routine screening or for a specific problem

PATIENT CHARACTERISTICS:

  • Not pregnant

PRIOR CONCURRENT THERAPY:

  • No concurrent participation in a clinical trial to treat cancer or prevent cancer recurrence
Sexes Eligible for Study: All
25 Years to 75 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00897403
CDR0000546530
P30CA068485 ( US NIH Grant/Contract Award Number )
VU-VICC-GI-0661
VU-VICC-IRB-061096
Not Provided
Not Provided
Not Provided
Not Provided
Daniel Liebler, Vanderbilt University Medical Center
Vanderbilt University
National Cancer Institute (NCI)
Study Chair: Daniel C. Liebler, PhD Vanderbilt-Ingram Cancer Center
Vanderbilt University
April 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP